Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver Patients

Sponsor
Ramy Salama Draz (Other)
Overall Status
Completed
CT.gov ID
NCT04046718
Collaborator
(none)
60
1
2
4.2
14.2

Study Details

Study Description

Brief Summary

sixty female patients suffering from non-alcoholic fatty liver disease were randomly divided into two equal groups group 1 received electroacupuncture stimulation for 6 weeks at special points of stimulation. group 2 was a control group that received nothing without any change in lifestyle and we assed the response of lipid profile post-treatment protocol in both groupes

Condition or Disease Intervention/Treatment Phase
  • Device: electro-acupuncture stimulation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
two group study, one is the study group and the other is a control grouptwo group study, one is the study group and the other is a control group
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Lipid Profile Response to Electroacupuncture
Actual Study Start Date :
Aug 22, 2019
Actual Primary Completion Date :
Nov 25, 2019
Actual Study Completion Date :
Dec 29, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: electroacupuncture

the study group received electroacupuncture stimulation at different points

Device: electro-acupuncture stimulation
stimulation of acupoints of the liver meridian of lv3 lv14

No Intervention: control group

a control group with no intervention

Outcome Measures

Primary Outcome Measures

  1. tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl) [6 weeks]

    lowering of total lipid profile in study group

Secondary Outcome Measures

  1. weight (kg) , height (m), BMI (kg/m2) [1st week]

    calculation of body mass index

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 55 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

non alcoholic fatty liver BMI 30-40

Exclusion Criteria:
  • Patients with: (Hepatitis C & b any form of seizure

Contacts and Locations

Locations

Site City State Country Postal Code
1 faculty of physical therapy Cairo university Cairo Egypt

Sponsors and Collaborators

  • Ramy Salama Draz

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Ramy Salama Draz, Principal Investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT04046718
Other Study ID Numbers:
  • P.T.REC/012/001579_1
First Posted:
Aug 6, 2019
Last Update Posted:
Aug 6, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 6, 2021